A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

Clinical trial NCT00620594 · COMPLETED

Trial details

NCT number: NCT00620594
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Advanced Solid Tumors Cowden Syndrome

Start date: 2006-12-21
Primary completion: 2013-01-08
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.